Filing Details

Accession Number:
0001209191-14-053490
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-08-19 19:19:15
Reporting Period:
2014-08-18
Filing Date:
2014-08-19
Accepted Time:
2014-08-19 18:19:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1571498 Epizyme Inc. EPZM Pharmaceutical Preparations (2834) 261349956
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1577021 A Robert Copeland C/O Epizyme, Inc.
400 Technology Square
Cambridge MA 02139
Evp And Cso No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0001 Per Share Disposition 2014-08-18 4,031 $35.93 1,274 No 4 S Direct
Common Stock, Par Value $0.0001 Per Share Disposition 2014-08-18 1,274 $36.52 0 No 4 S Direct
Common Stock, Par Value $0.0001 Per Share Disposition 2014-08-18 4,199 $35.93 1,326 No 4 S Indirect By Wife
Common Stock, Par Value $0.0001 Per Share Disposition 2014-08-18 1,326 $36.52 0 No 4 S Indirect By Wife
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Indirect By Wife
No 4 S Indirect By Wife
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.31 per share to $36.28 per share, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.31 per share to $36.74 per share, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.